Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL BLOOD CULTURE TESTS MARKET SIZE IS EXPECTED TO REACH USD 8.98 BILLION BY 2029 FROM USD 5.72 BILLION IN 2023, GROWING AT A CAGR OF 7.81% DURING THE FORECAST PERIOD.
The Blood Culture Tests Market Size, Share, & Trends Analysis Report By
· Sample Type: Bacterial Sample and Non-bacterial Sample
· Method: Manual/Conventional Blood Culture and Automated Blood Culture
· Product: Consumables and Test Equipment
· End-users: Hospital-based Laboratories, Clinical Laboratories, Academic & Research Laboratories/Centers, and Others
· Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
GLOBAL BLOOD CULTURE TESTS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Market Size (2029) | USD 8.98 Billion |
| Market Size (2023) | USD 5.72 Billion |
| CAGR (2023-2029) | 7.81% |
| HISTORIC YEAR | 2020-2022 |
| BASE YEAR | 2023 |
| FORECAST YEAR | 2024-2029 |
| SEGMENTS BY | Sample Type, Method, Product, End-users, Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | BD, BIOMÉRIEUX, Bruker, Danaher, Terumo Corporation, and Thermo Fisher Scientific |
MARKET INSIGHTS
The global blood culture tests market was valued at USD 5.72 billion in 2023 and is expected to reach USD 8.98 billion by 2029, growing at a CAGR of 7.81% during the forecast period. The estimated growth of the market is based on the various market dynamics, including continued growth and development in blood culture tests, a growing patient population with infectious diseases, and growing awareness about diagnosis and care for infectious diseases. Blood culture tests identify bacteria or fungi in blood samples. It remains the greatest approach to detect the incriminating microbes when a bloodstream infection is suspected and to guarantee that the antimicrobial treatment is appropriate. Blood culture tests currently represent the major method to identify the aetiology of bloodstream infections because they are highly sensitive and easy to perform. Furthermore, the continued development of in-blood culture test systems is increasing competition among vendors. Technological development, product launches, and the continued integration of advanced tools offer significant blood culture tests market growth opportunities.
MARKET OPPORTUNITIES & TRENDS
Rising Development with Automated Blood Culture Test Systems
The automated blood culture test systems are a ray of hope in the blood culture tests market to increase the speed of diagnosis and reduce contamination rate. With the rising demand for rapid diagnosis of blood-associated and other infectious diseases, the requirement for advanced blood culture test systems is rapidly increasing across the market. These advanced systems are intended to make blood culture processing more efficient and streamlined, as stated by the National Library of Medicine Report 2021. Also, these systems reduce the demand for terminal or blind subculture bottles and increase the speed of test procedures. These systems are effective and efficient and increase blood culture test specificity and sensitivity; these factors are expected to deliver new market growth opportunities.
Advances in Blood Culture Testing
The development and innovation of new technologies for blood culture testing are accelerating the blood culture tests market growth. Bloodstream diseases are a significant cause of severe health outcomes and death with growing incidence and severity. A general blood culture test is the standard method; however, the upcoming new technologies and advances, such as molecular-based diagnostics, are used as add-on complementary assays. It increases test speed and speed-up microbial detection and guesses antimicrobial susceptibility. Furthermore, innovations for blood culture testing, such as molecular testing technologies, are more accurate and sensitive than traditional methods. In the past few years, diagnosing bloodstream infections has relied on time-consuming basic blood cultures coupled with traditional organism identification and susceptibility testing. Technologies to define the culprit in bloodstream infections have gained sophistication in recent years, notably by applying molecular diagnostic methods.
Growing Demand for Early & Preventive Diagnosis
Globally, the rising concern about health drives the demand for early disease diagnosis, positively influencing the blood culture tests market growth. The accurate and early diagnosis of diseases is essential to prevent wasting patients' valuable time on the wrong course of treatments. When a patient gets an accurate diagnosis, it offers the best opportunities for positive health outcomes with the help of clinical decisions tailored to a correct understanding of the patient’s health issues. Bloodstream infections, specifically sepsis, are highly demanded for early and preventive diagnosis. Several government initiatives and healthcare policies favor early sepsis and other bloodstream infections. Also, the growing importance of accurate diagnosis is the leading factor accelerating the preference for blood culture tests in infectious disease management. Medical errors are one of the leading causes of death worldwide and were one of the leading causes of death in the U.S. in the past few years. The growing importance of accurate diagnosis of infectious diseases is accelerating visits to clinical laboratories and boosting the demand for blood culture tests and associated equipment and consumables.
SEGMENTATION INSIGHTS
INSIGHTS BY SAMPLE TYPE
The global blood culture tests market by sample type is segmented into bacterial and non-bacterial samples. During the forecast period, the bacterial sample type segment accounted for the highest market share and dominated the market. Bacterial pathogens are significantly prevalent in bloodstream infections compared to another pathogen. Bacterial pathogens severely impact human health and drive the demand for early and preventive diagnosis, where the bacterial sample is commonly used in blood culture testing and accelerates segmental growth.
INSIGHTS BY METHOD
The global blood culture tests market by method is segmented into manual/conventional blood culture and automated blood culture. Manual/conventional blood culture methods are traditional and familiar to lab operators. These methods are used longer, giving them high popularity and acceptance. In 2023, the manual/conventional blood culture method segment accounted for the largest share of the market. Manual/conventional blood culture methods are commonly used due to the convenience and affordability of required solutions. Conversely, automated blood culture methods are becoming more popular in recent years. The automation in sample processing gives high efficacy, resulting in the best delivery result. Also, automated blood culture systems are becoming more popular and the primary choice to identify pathogens from blood samples. Rather than manually reading broth-based conventional methods, labs now use continuously monitored automated systems to process blood culture samples.
INSIGHTS BY PRODUCT
The consumables product segment holds the most significant share of the global blood culture tests market in 2023. Consumables are in high demand due to their repetitive use in blood culture testing at all diagnostic laboratories and research centers. Also, some consumables can be used only once and must be discarded or replaced after some time. It increases the application rate and demand for consumables over test equipment. Further, the consumables include a range of solutions used in general to standard laboratories, which include reagents, filters, tubes, plates, and gloves. These consumables are commonly in demand in hospitals, life sciences, academic laboratories, and others.
INSIGHTS BY END-USERS
The global blood culture tests market by end-users is segmented into hospital-based laboratories, clinical laboratories, academic and research laboratories/centers, and others. The hospital-based laboratories segment accounted for more than 45% of the highest market share in 2023. Blood culture tests are commonly performed in hospital-associated laboratory centers due to a significant patient population with infectious diseases and a higher prevalence of bloodstream infection in hospital settings. Hospital-acquired infections and associated risks commonly require blood culture tests and significantly contribute to segmental revenue growth.
GEOGRAPHICAL ANALYSIS
North America holds the largest share of the global blood culture tests market, accounting for a global revenue share of 35% in 2023. The region holds a significant market share due to the increasing burden of bloodstream infection across hospital settings, the rising burden of sepsis management, and the growing awareness and acceptance of automated blood culture systems. In addition, the presence of major market players in the U.S. accelerates the influencing demand and adoption of blood culture test equipment and consumables, fueling market growth.
APAC is expected to witness the highest CAGR in the global blood culture tests market during the forecast period. The market growth in APAC is anticipated with the increasing burden of infectious diseases, such as bloodstream infection, sepsis, hospital-associated infection, and others. In addition, the rapid development in healthcare and life sciences is accelerating market growth. China and India are the two leading countries that have witnessed increasing development in the diagnostics field for preventive measures, and early diagnosis of infectious diseases is expected to drive significant market growth in these countries.
VENDOR LANDSCAPE
Vendors can understand that the traditional blood culture test methods are the most used method over automated blood culture systems, where the automated systems are becoming a new ray of hope in the blood culture tests market. Vendors can develop advanced automated blood culture systems and achieve revenue growth opportunities. Furthermore, globally, bloodstream infection (BSI) and sepsis cases are most commonly reported in healthcare settings, where the demand for blood culture tests is continuously rising and is expected to deliver huge revenue growth opportunities.
Very few automated blood culture test systems are available, and their acceptance is rising steadily in the market, which is a significant opportunity for vendors to develop new solutions. Also, there has been a slow shift from manual to automated blood culture test methods, where vendors can focus on increasing their market penetration by launching new automated systems.
North America is one of the major blood culture test markets; on the other hand, APAC is a rapidly growing market landscape for blood culture tests due to the increasing burden of BSI and a huge patient population. Emerging countries are witnessing a high burden of sepsis, which is commonly diagnosed with manual blood culture tests. Vendors can focus on delivering affordable consumables and test equipment for emerging markets. Furthermore, blood culture tests are the gold standard in BSI and sepsis diagnosis, and alternative methods are available. Vendors can focus on decreasing result delivery time with molecular diagnosis technology.
SNAPSHOT
The global blood culture tests market is expected to grow at a CAGR of approximately 7.81% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global blood culture tests market during the forecast period:
- Increasing Prevalence of Sepsis
- Rising Burden of Bloodstream Infections
- Growing Demand for Early & Preventive Diagnosis
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global blood culture tests market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
- BDBusiness Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- BIOMÉRIEUX
- Bruker
- Danaher
- Terumo Corporation
- Thermo Fisher Scientific
Other Prominent Vendors
- AbbottBusiness Overview
- Product Offerings
- Autobio
- Axiom
- Biolab Scientific
- Cardinal Health
- DiaSorin S.p.A.
- F. Hoffmann-La Roche
- Hardy Diagnostics
- HiMedia Laboratories
- ITL BioMedical
- Kurin Inc
- Labotronics Scientific
- Meditech Technologies India Private Limited
- OpGen
- Render Biotech Co., Ltd.
- SARSTEDT AG & Co KG
- Siemens Healthineers AG
- Scenker Biological Technology Co., Ltd
- T2 Biosystems (T2Bio)
Segmentation by Sample Type
- Bacterial Sample
- Non-bacterial Sample
Segmentation by Method
- Manual/Conventional Blood Culture
- Automated Blood Culture
Segmentation by Product
- Consumables
- Test Equipment
Segmentation by End-users
- Hospital-based Laboratories
- Clinical Laboratories
- Academic & Research Laboratories/Centers
- Others
Segmentation by Geography
- North AmericaThe U.S.
- Canada
- EuropeGermany
- France
- The U.K.
- Italy
- Spain
- Russia
- Poland
- APACChina
- India
- Japan
- South Korea
- Australia
- Indonesia
- Latin AmericaBrazil
- Mexico
- Argentina
- Middle East & AfricaTurkey
- Saudi Arabia
- South Africa
- UAE
Frequently Asked Questions
How big is the blood culture tests market?
Which region dominates the global blood culture tests market share?
What are the significant trends in the blood culture tests market?
What is the growth rate of the global blood culture tests market?
Who are the key players in the global blood culture tests market?
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2023
EXHIBIT 2 DYNAMICS OF BLOOD CULTURE TESTS MARKET
EXHIBIT 3 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 4 BLOOD CULTURE TESTS ARE RECOMMENDED TO IDENTIFY
EXHIBIT 5 IMPACT OF GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
EXHIBIT 6 KEY RECOMMENDATION BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAYS
EXHIBIT 7 BLOOD CULTURE CONTAMINATION RATE BEFORE & AFTER INTERVENTION IN SAUDI ARABIA (2020– 2021)
EXHIBIT 8 IMPACT OF RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TESTS
EXHIBIT 9 IMPACT OF ADVANCES IN BLOOD CULTURE TESTING
EXHIBIT 10 AVAILABLE MOLECULAR METHODS FOR POSITIVE BLOOD CULTURES
EXHIBIT 11 IMPACT OF INCREASE IN PREVALENCE OF SEPSIS
EXHIBIT 12 SEPSIS PREVALENCE 2022
EXHIBIT 13 IMPACT OF RISE IN BURDEN OF BLOODSTREAM INFECTIONS
EXHIBIT 14 BLOODSTREAM INFECTIONS
EXHIBIT 15 IMPACT OF INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
EXHIBIT 16 IMPACT OF CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
EXHIBIT 17 CONSEQUENCES OF BLOOD CULTURE CONTAMINATION
EXHIBIT 18 IMPACT OF FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
EXHIBIT 19 IMPACT OF FALSE POSITIVE BLOOD CULTURE RESULTS (2022)
EXHIBIT 20 IMPACT OF ALTERNATIVES TO BLOOD CULTURE TESTS
EXHIBIT 21 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029
EXHIBIT 22 GLOBAL BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 23 GLOBAL BLOOD CULTURE TESTS MARKET BY SEGMENT
EXHIBIT 24 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE
EXHIBIT 25 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD
EXHIBIT 26 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT
EXHIBIT 27 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER
EXHIBIT 28 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY
EXHIBIT 29 FIVE FORCES ANALYSIS 2023
EXHIBIT 30 INCREMENTAL GROWTH BY SAMPLE TYPE 2023 & 2029
EXHIBIT 31 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029
EXHIBIT 32 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: INCREMENTAL GROWTH
EXHIBIT 33 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE: ABSOLUTE GROWTH
EXHIBIT 34 BLOODSTREAM INFECTION CAUSING BACTERIAL PATHOGENS (1997–2019) (%)
EXHIBIT 35 GLOBAL BLOOD CULTURE TESTS MARKET BY BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 37 GLOBAL BLOOD CULTURE TESTS MARKET BY NON-BACTERIAL SAMPLE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY METHOD 2023 & 2029
EXHIBIT 40 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029
EXHIBIT 41 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: INCREMENTAL GROWTH
EXHIBIT 42 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD: ABSOLUTE GROWTH
EXHIBIT 43 GLOBAL BLOOD CULTURE TESTS MARKET BY MANUAL/CONVENTIONAL BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 45 ADVANTAGES OF AUTOMATED BLOOD CULTURE
EXHIBIT 46 GLOBAL BLOOD CULTURE TESTS MARKET BY AUTOMATED BLOOD CULTURE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY PRODUCT 2023 & 2029
EXHIBIT 49 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029
EXHIBIT 50 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 51 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 52 CONSUMABLES REQUIRED IN BLOOD CULTURE TESTS
EXHIBIT 53 GLOBAL BLOOD CULTURE TESTS MARKET BY CONSUMABLES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET 2020–2029 ($ BILLION)
EXHIBIT 55 GLOBAL BLOOD CULTURE TESTS MARKET BY TEST EQUIPMENT: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET 2020–2029 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY END-USER 2023 & 2029
EXHIBIT 58 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029
EXHIBIT 59 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 60 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL BLOOD CULTURE TESTS MARKET BY HOSPITAL-BASED LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 62 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 63 GLOBAL BLOOD CULTURE TESTS MARKET BY CLINICAL LABORATORIES: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 65 GLOBAL BLOOD CULTURE TESTS MARKET BY ACADEMIC & RESEARCH LABORATORIES/CENTERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 66 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 67 GLOBAL BLOOD CULTURE TESTS MARKET BY OTHERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 68 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY 2023 & 2029
EXHIBIT 70 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029
EXHIBIT 71 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 KEY COUNTRIES IN NORTH AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 74 NORTH AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 76 INCREMENTAL GROWTH IN NORTH AMERICA 2023 & 2029
EXHIBIT 77 SEPSIS STATISTICS IN US 2022
EXHIBIT 78 US BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 79 BLOODSTREAM INFECTION CASES BY HEALTHCARE SETTINGS (2022)
EXHIBIT 80 CANADA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 81 EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES GUIDELINES (2012)
EXHIBIT 82 KEY COUNTRIES IN EUROPE BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 83 EUROPE BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 84 EUROPE BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 85 INCREMENTAL GROWTH IN EUROPE 2023 & 2029
EXHIBIT 86 GERMANY BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 87 FRANCE BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 88 RECOMMENDATIONS BY NHS ENGLAND TO IMPROVE BLOOD CULTURE PATHWAY
EXHIBIT 89 UK BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 90 ITALY BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 91 SPAIN BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 92 RUSSIA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 93 POLAND BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 94 KEY COUNTRIES IN APAC BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 95 SEPSIS PREVALENCE IN ASIAN COUNTRIES BY INCOME GROUP (2020)
EXHIBIT 96 APAC BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 97 APAC BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 98 INCREMENTAL GROWTH IN APAC 2023 & 2029
EXHIBIT 99 CHINA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 100 INDIA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 101 JAPAN BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 102 SOUTH KOREA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 103 AUSTRALIA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 104 INDONESIA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 105 KEY COUNTRIES IN LATIN AMERICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 106 LATIN AMERICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 107 LATIN AMERICA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2023 & 2029
EXHIBIT 109 BRAZIL BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 110 MEXICO BLOOD CULTURE TESTS MARKET 2023–2029 ($ BILLION)
EXHIBIT 111 ARGENTINA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 112 KEY COUNTRIES IN MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2023 (REVENUE IN $ BILLION)
EXHIBIT 113 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 114 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 115 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2023 & 2029
EXHIBIT 116 EPIDEMIOLOGY & PREVALENCE OF SEPSIS IN ICUS IN TURKEY (2020)
EXHIBIT 117 TURKEY BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 118 SAUDI ARABIA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 119 SOUTH AFRICA BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 120 UAE BLOOD CULTURE TESTS MARKET 2020–2029 ($ BILLION)
EXHIBIT 121 MARKET DOMINANCE ANALYSIS OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 122 CAPABILITIES & EXPERT ASSESSMENT OF VENDORS OFFERING BLOOD CULTURE TESTS
EXHIBIT 123 ANNUAL REVENUE OF BD 2021–2023 ($ BILLION)
EXHIBIT 124 ANNUAL REVENUE OF BD BY GEOGRAPHY 2023 (%)
EXHIBIT 125 ANNUAL REVENUE OF BIOMÉRIEUX 2020-2022 ($ MILLION)
EXHIBIT 126 ANNUAL REVENUE OF BIOMÉRIEUX BY GEOGRAPHY 2022 (%)
EXHIBIT 127 ANNUAL REVENUE OF BRUKER 2020–2022 ($ BILLION)
EXHIBIT 128 ANNUAL REVENUE OF DANAHER 2020-2022 ($ BILLION)
EXHIBIT 129 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC 2020–2022 ($ BILLION)
EXHIBIT 130 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY SEGMENT 2022 (%)
EXHIBIT 131 ANNUAL REVENUE OF THERMO FISHER SCIENTIFIC BY GEOGRAPHY 2022 (%)
EXHIBIT 132 KEY CAVEATS
LIST OF TABLES
TABLE 1 INDICATIONS FOR TAKING BLOOD CULTURE
TABLE 2 PRODUCT LAUNCHED IN GLOBAL BLOOD CULTURE TESTS MARKET
TABLE 3 STRATEGIC DEVELOPMENTS IN GLOBAL BLOOD CULTURE TESTS MARKET
TABLE 4 MOLECULAR METHODS FROM POSITIVE BLOOD CULTURE BOTTLES
TABLE 5 GLOBAL SEPSIS STATISTICS 2022
TABLE 6 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 7 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 8 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 9 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 10 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 11 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 12 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 13 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 14 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 15 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 16 SOME AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 17 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 18 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 19 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 20 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 21 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 22 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 23 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 24 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 25 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 26 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 27 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 28 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 29 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 30 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 31 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 32 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 33 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 34 NORTH AMERICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 35 EUROPE BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 36 EUROPE BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 37 EUROPE BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 38 EUROPE BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 39 EUROPE BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 40 EUROPE BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 41 EUROPE BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 42 EUROPE BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 43 APAC BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 44 APAC BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 45 APAC BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 46 APAC BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 47 APAC BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 48 APAC BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 49 APAC BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 50 APAC BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 51 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 52 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 53 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 54 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 55 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 56 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 57 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 58 LATIN AMERICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 59 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 60 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 61 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 62 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 63 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 64 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 65 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 66 MIDDLE EAST & AFRICA BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 67 TOTAL REVENUE OF KEY COMPANIES IN BLOOD CULTURE TESTS MARKET 2022
TABLE 68 BD: MAJOR PRODUCT OFFERINGS
TABLE 69 BIOMÉRIEUX: MAJOR PRODUCT OFFERINGS
TABLE 70 BRUKER: MAJOR PRODUCT OFFERINGS
TABLE 71 DANAHER: MAJOR PRODUCT OFFERINGS
TABLE 72 TERUMO CORPORATION: MAJOR PRODUCT OFFERINGS
TABLE 73 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 74 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 75 AUTOBIO: MAJOR PRODUCT OFFERINGS
TABLE 76 AXIOM: MAJOR PRODUCT OFFERINGS
TABLE 77 BIOLAB SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 78 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 79 DIASORIN S.P.A.: MAJOR PRODUCT OFFERINGS
TABLE 80 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS
TABLE 81 HARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 82 HIMEDIA LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 83 ITL BIOMEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 84 KURIN INC: MAJOR PRODUCT OFFERINGS
TABLE 85 LABOTRONICS SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 86 MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 87 OPGEN: MAJOR PRODUCT OFFERINGS
TABLE 88 RENDER BIOTECH CO., LTD.: MAJOR PRODUCT OFFERINGS
TABLE 89 SARSTEDT AG & CO KG: MAJOR PRODUCT OFFERINGS
TABLE 90 SIEMENS HEALTHINEERS AG: MAJOR PRODUCT OFFERINGS
TABLE 91 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD: MAJOR PRODUCT OFFERINGS
TABLE 92 T2 BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 93 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 ($ BILLION)
TABLE 94 GLOBAL BLOOD CULTURE TESTS MARKET BY SAMPLE TYPE 2023–2029 (%)
TABLE 95 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 ($ BILLION)
TABLE 96 GLOBAL BLOOD CULTURE TESTS MARKET BY METHOD 2023–2029 (%)
TABLE 97 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 ($ BILLION)
TABLE 98 GLOBAL BLOOD CULTURE TESTS MARKET BY PRODUCT 2023–2029 (%)
TABLE 99 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 ($ BILLION)
TABLE 100 GLOBAL BLOOD CULTURE TESTS MARKET BY END-USER 2023–2029 (%)
TABLE 101 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 102 GLOBAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 103 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 104 GLOBAL BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 105 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 106 GLOBAL NON-BACTERIAL SAMPLE BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 107 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 108 GLOBAL MANUAL/CONVENTIONAL BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 109 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 110 GLOBAL AUTOMATED BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 111 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 112 GLOBAL BLOOD CULTURE TESTS CONSUMABLES MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 113 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 114 GLOBAL BLOOD CULTURE TEST EQUIPMENT MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 115 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 116 GLOBAL HOSPITAL-BASED LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 117 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 118 GLOBAL CLINICAL LABORATORIES BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 119 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 120 GLOBAL ACADEMIC & RESEARCH LABORATORIES/CENTERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 121 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 ($ BILLION)
TABLE 122 GLOBAL OTHERS BLOOD CULTURE TESTS MARKET BY GEOGRAPHY 2023–2029 (%)
TABLE 123 CURRENCY CONVERSION 2016−2023
1 SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. SEGMENTS COVERED & DEFINITION
1.2.1. MARKET BY SAMPLE TYPE
1.2.2. MARKET BY METHOD
1.2.3. MARKET BY PRODUCT
1.2.4. MARKET BY END-USER
1.2.5. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. HISTORIC, BASE, & FORECAST YEARS
2 PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
2.2.1. MARKET OPPORTUNITIES & TRENDS
2.2.2. MARKET DRIVERS/ENABLERS
2.2.3. MARKET SEGMENTATION
2.2.4. MARKET INSIGHTS
3 MARKET AT A GLANCE
4 INTRODUCTION
4.1. OVERVIEW
5 MARKET OPPORTUNITIES & TRENDS
5.1. GROWTH & DEVELOPMENT IN BLOOD CULTURE PATHWAY
5.2. RISING DEVELOPMENT WITH AUTOMATED BLOOD CULTURE TEST SYSTEMS
5.3. ADVANCES IN BLOOD CULTURE TESTING
6 MARKET GROWTH ENABLERS
6.1 INCREASE IN PREVALENCE OF SEPSIS
6.2 RISE IN BURDEN OF BLOODSTREAM INFECTIONS
6.3 INCREASE IN DEMAND FOR EARLY & PREVENTIVE DIAGNOSIS
7 MARKET RESTRAINTS
7.1 CONTAMINATION IS MAJOR CHALLENGE FOR BLOOD CULTURE TESTS
7.2 FALSE POSITIVE & NEGATIVE ERRORS AND ASSOCIATED IMPACTS
7.3 ALTERNATIVES TO BLOOD CULTURE TESTS
8 MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.2.1. MARKET BY SAMPLE TYPE
8.2.2. MARKET BY METHOD
8.2.3. MARKET BY PRODUCT
8.2.4. MARKET BY END-USER
8.2.5. MARKET BY GEOGRAPHY
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9 SAMPLE TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. BACTERIAL SAMPLE
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. NON-BACTERIAL SAMPLE
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
10 METHOD
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. MANUAL/CONVENTIONAL BLOOD CULTURE
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. AUTOMATED BLOOD CULTURE
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
11 PRODUCT
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. CONSUMABLES
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. TEST EQUIPMENT
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
12 END-USER
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. HOSPITAL-BASED LABORATORIES
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. MARKET BY GEOGRAPHY
12.4. CLINICAL LABORATORIES
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. MARKET BY GEOGRAPHY
12.5. ACADEMIC & RESEARCH LABORATORIES/CENTERS
12.5.1. MARKET OVERVIEW
12.5.2. MARKET SIZE & FORECAST
12.5.3. MARKET BY GEOGRAPHY
12.6. OTHERS
12.6.1. MARKET OVERVIEW
12.6.2. MARKET SIZE & FORECAST
12.6.3. MARKET BY GEOGRAPHY
13 GEOGRAPHY
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. GEOGRAPHIC OVERVIEW
14 NORTH AMERICA
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.3. SAMPLE TYPE
14.3.1. MARKET SIZE & FORECAST
14.4. METHOD
14.4.1. MARKET SIZE & FORECAST
14.5. PRODUCT
14.5.1. MARKET SIZE & FORECAST
14.6. END-USER
14.6.1. MARKET SIZE & FORECAST
14.7. KEY COUNTRIES
14.7.1. US: MARKET SIZE & FORECAST
14.7.2. CANADA: MARKET SIZE & FORECAST
15 EUROPE
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.3. SAMPLE TYPE
15.3.1. MARKET SIZE & FORECAST
15.4. METHOD
15.4.1. MARKET SIZE & FORECAST
15.5. PRODUCT
15.5.1. MARKET SIZE & FORECAST
15.6. END-USER
15.6.1. MARKET SIZE & FORECAST
15.7. KEY COUNTRIES
15.7.1. GERMANY: MARKET SIZE & FORECAST
15.7.2. FRANCE: MARKET SIZE & FORECAST
15.7.3. UK: MARKET SIZE & FORECAST
15.7.4. ITALY: MARKET SIZE & FORECAST
15.7.5. SPAIN: MARKET SIZE & FORECAST
15.7.6. RUSSIA: MARKET SIZE & FORECAST
15.7.7. POLAND: MARKET SIZE & FORECAST
16 APAC
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.3. SAMPLE TYPE
16.3.1. MARKET SIZE & FORECAST
16.4. METHOD
16.4.1. MARKET SIZE & FORECAST
16.5. PRODUCT
16.5.1. MARKET SIZE & FORECAST
16.6. END-USER
16.6.1. MARKET SIZE & FORECAST
16.7. KEY COUNTRIES
16.7.1. CHINA: MARKET SIZE & FORECAST
16.7.2. INDIA: MARKET SIZE & FORECAST
16.7.3. JAPAN: MARKET SIZE & FORECAST
16.7.4. SOUTH KOREA: MARKET SIZE & FORECAST
16.7.5. AUSTRALIA: MARKET SIZE & FORECAST
16.7.6. INDONESIA: MARKET SIZE & FORECAST
17 LATIN AMERICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.3. SAMPLE TYPE
17.3.1. MARKET SIZE & FORECAST
17.4. METHOD
17.4.1. MARKET SIZE & FORECAST
17.5. PRODUCT
17.5.1. MARKET SIZE & FORECAST
17.6. END-USER
17.6.1. MARKET SIZE & FORECAST
17.7. KEY COUNTRIES
17.7.1. BRAZIL: MARKET SIZE & FORECAST
17.7.2. MEXICO: MARKET SIZE & FORECAST
17.7.3. ARGENTINA: MARKET SIZE & FORECAST
18 MIDDLE EAST & AFRICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.3. SAMPLE TYPE
18.3.1. MARKET SIZE & FORECAST
18.4. METHOD
18.4.1. MARKET SIZE & FORECAST
18.5. PRODUCT
18.5.1. MARKET SIZE & FORECAST
18.6. END-USER
18.6.1. MARKET SIZE & FORECAST
18.7. KEY COUNTRIES
18.7.1. TURKEY: MARKET SIZE & FORECAST
18.7.2. SAUDI ARABIA: MARKET SIZE & FORECAST
18.7.3. SOUTH AFRICA: MARKET SIZE & FORECAST
18.7.4. UAE: MARKET SIZE & FORECAST
19 COMPETITIVE LANDSCAPE
19.1. COMPETITION OVERVIEW
19.2. MARKET SHARE ANALYSIS
19.2.1. BD
19.2.2. BIOMÉRIEUX
19.2.3. BRUKER
19.2.4. DANAHER
19.2.5. TERUMO CORPORATION
19.2.6. THERMO FISHER SCIENTIFIC
20 KEY COMPANY PROFILES
20.1. BD
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.1.3. KEY STRATEGIES
20.1.4. KEY STRENGTHS
20.1.5. KEY OPPORTUNITIES
20.2. BIOMÉRIEUX
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.2.3. KEY STRATEGIES
20.2.4. KEY STRENGTHS
20.2.5. KEY OPPORTUNITIES
20.3. BRUKER
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.3.3. KEY STRATEGIES
20.3.4. KEY STRENGTHS
20.3.5. KEY OPPORTUNITIES
20.4. DANAHER
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.4.3. KEY STRATEGIES
20.4.4. KEY STRENGTHS
20.4.5. KEY OPPORTUNITIES
20.5. TERUMO CORPORATION
20.5.1. BUSINESS OVERVIEW
20.5.2. PRODUCT OFFERINGS
20.5.3. KEY STRATEGIES
20.5.4. KEY STRENGTHS
20.5.5. KEY OPPORTUNITIES
20.6. THERMO FISHER SCIENTIFIC
20.6.1. BUSINESS OVERVIEW
20.6.2. PRODUCT OFFERINGS
20.6.3. KEY STRATEGIES
20.6.4. KEY STRENGTHS
20.6.5. KEY OPPORTUNITIES
21 OTHER PROMINENT VENDORS
21.1. ABBOTT
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.2. AUTOBIO
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.3. AXIOM
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.4. BIOLAB SCIENTIFIC
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.5. CARDINAL HEALTH
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.6. DIASORIN S.P.A.
21.6.1. BUSINESS OVERVIEW
21.6.2. PRODUCT OFFERINGS
21.7. F. HOFFMANN-LA ROCHE
21.7.1. BUSINESS OVERVIEW
21.7.2. PRODUCT OFFERINGS
21.8. HARDY DIAGNOSTICS
21.8.1. BUSINESS OVERVIEW
21.8.2. PRODUCT OFFERINGS
21.9. HIMEDIA LABORATORIES
21.9.1. BUSINESS OVERVIEW
21.9.2. PRODUCT OFFERINGS
21.10. ITL BIOMEDICAL
21.10.1. BUSINESS OVERVIEW
21.10.2. PRODUCT OFFERINGS
21.11. KURIN INC
21.11.1. BUSINESS OVERVIEW
21.11.2. PRODUCT OFFERINGS
21.12. LABOTRONICS SCIENTIFIC
21.12.1. BUSINESS OVERVIEW
21.12.2. PRODUCT OFFERINGS
21.13. MEDITEC TECHNOLOGIES INDIA PRIVATE LIMITED
21.13.1. BUSINESS OVERVIEW
21.13.2. PRODUCT OFFERINGS
21.14. OPGEN
21.14.1. BUSINESS OVERVIEW
21.14.2. PRODUCT OFFERINGS
21.15. RENDER BIOTECH CO., LTD
21.15.1. BUSINESS OVERVIEW
21.15.2. PRODUCT OFFERINGS
21.16. SARSTEDT AG & CO KG
21.16.1. BUSINESS OVERVIEW
21.16.2. PRODUCT OFFERINGS
21.17. SIEMENS HEALTHINEERS AG
21.17.1. BUSINESS OVERVIEW
21.17.2. PRODUCT OFFERINGS
21.18. SCENKER BIOLOGICAL TECHNOLOGY CO., LTD
21.18.1. BUSINESS OVERVIEW
21.18.2. PRODUCT OFFERINGS
21.19. T2 BIOSYSTEMS (T2BIO)
21.19.1. BUSINESS OVERVIEW
21.19.2. PRODUCT OFFERINGS
22 REPORT SUMMARY
22.1. KEY TAKEAWAYS
22.2. STRATEGIC RECOMMENDATIONS
23 QUANTITATIVE SUMMARY
23.1. MARKET BY SAMPLE TYPE
23.2. MARKET BY METHOD
23.3. MARKET BY PRODUCT
23.4. MARKET BY END-USER
23.5. MARKET BY GEOGRAPHY
23.6. SAMPLE TYPE: MARKET BY GEOGRAPHY
23.6.1. BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
23.6.2. NON-BACTERIAL SAMPLE: MARKET BY GEOGRAPHY
23.7. METHOD: MARKET BY GEOGRAPHY
23.7.1. MANUAL/CONVENTIONAL BLOOD CULTURE: MARKET BY GEOGRAPHY
23.7.2. AUTOMATED BLOOD CULTURE: MARKET BY GEOGRAPHY
23.8. PRODUCT: MARKET BY GEOGRAPHY
23.8.1. CONSUMABLES: MARKET BY GEOGRAPHY
23.8.2. TEST EQUIPMENT: MARKET BY GEOGRAPHY
23.9. END-USER: MARKET BY GEOGRAPHY
23.9.1. HOSPITAL-BASED LABORATORIES: MARKET BY GEOGRAPHY
23.9.2. CLINICAL LABORATORIES: MARKET BY GEOGRAPHY
23.9.3. ACADEMIC & RESEARCH LABORATORIES/CENTERS: MARKET BY GEOGRAPHY
23.9.4. OTHERS: MARKET BY GEOGRAPHY
24 APPENDIX
24.1. RESEARCH METHODOLOGY
24.2. RESEARCH PROCESS
24.3. REPORT ASSUMPTIONS & CAVEATS
24.3.1. KEY CAVEATS
24.3.2. CURRENCY CONVERSION
24.4. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the blood culture tests market?
Which region dominates the global blood culture tests market share?
What are the significant trends in the blood culture tests market?
What is the growth rate of the global blood culture tests market?
Who are the key players in the global blood culture tests market?
Other RELATED Reports
Blood Glucose Test Strips Market - Global Outlook and Forecast 2021-2026
Published : May 2021
U.S. Clinical Laboratory Test Market - Industry Outlook & Forecast 2021-2026
Published : June 2021
